Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

4 treatments under study, led by Ercp Endoscopic Retrograde Cholangiopancreatography

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Phase 1/2 (1)

Trial Status

Completed2

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT06694038Phase 1/2CompletedPrimary

Needle-Knife Fistulotomy Vs. Standard Cannulation Trial

NCT02281019Completed

SpyGlass AMEA Registry

Showing all 2 trials

Research Network

Common Treatments

  • Ercp Endoscopic Retrograde Cholangiopancreatography1
  • Spyglass Dvs And Spyglass Digital Simple Ds1
  • Needle Knife Fistulotomy1
  • Standard Biliary Cannulation1

Active Sponsors

  • Boston Scientific Corporation1
  • Thomas Jefferson University1

Top Investigators

Related Conditions

  • Biliary Stricture1
  • Malignant Bile Duct Obstruction1
  • Hemobilia1
  • Periampullary Tumor1

Activity Timeline